A detailed history of Murphy & Mullick Capital Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 13,482 shares of PFE stock, worth $338,128. This represents 0.25% of its overall portfolio holdings.

Number of Shares
13,482
Previous 11,642 15.8%
Holding current value
$338,128
Previous $279 Million 19.53%
% of portfolio
0.25%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$23.29 - $25.88 $42,853 - $47,619
1,840 Added 15.8%
13,482 $333 Million
Q2 2025

Aug 14, 2025

BUY
$21.59 - $24.84 $43,784 - $50,375
2,028 Added 21.09%
11,642 $279 Million
Q1 2025

May 14, 2025

BUY
$25.01 - $27.13 $18,482 - $20,049
739 Added 8.33%
9,614 $244 Million
Q4 2024

Feb 11, 2025

BUY
$24.8 - $30.19 $220,100 - $267,936
8,875 New
8,875 $235 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Murphy & Mullick Capital Management Corp Portfolio

Follow Murphy & Mullick Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy & Mullick Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Murphy & Mullick Capital Management Corp with notifications on news.